𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cutaneous T-cell lymphoma treatment using bexarotene and PUVA: A case series

✍ Scribed by Fiza Singh; Mark G. Lebwohl

Book ID
116578357
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
89 KB
Volume
51
Category
Article
ISSN
1097-6787

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

CD8+ cutaneous T-cell lymphoma successfu
CD8+ cutaneous T-cell lymphoma successfully treated with bexarotene: A case report and review of the literature
✍ Srivalli Gopaluni; Raiza Perzova; Lynn Abbott; Ramsey Farah; Anthony Shrimpton; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 132 KB πŸ‘ 2 views

## Abstract CD8+ cutaneous T‐cell lymphoma (CTCL) is a relatively rare subset of the non‐Hodgkins lymphomas. Bexarotene has been FDA‐approved for the treatment of CTCL, but previous studies have been conducted on CD4+ CTL and there have been no reports about its use in CD8+ CTCL. Herein, we report